Considering the data and including two patients of the authors, there exist only 18 authentic cases of primary malignant melanoma of the lower respiratory tract and/or the lung. The tumor was localized in the endobronchial space in 7 cases and only once in the trachea. Endobronchial localization, together with the involvement of the surrounding lung tissue, was found in two cases, whereas in 8 patients, the tumor was found exclusively in the lung parenchyma. Successful resection could be performed in 14 of the 18 cases. Survival was influenced primarily by operability, and on actual size and extension. The authors question the role of the obduction in the diagnostic criteria, because most of the survivors, even up to ten years postsurgery were considered primary. Apart from the various imaging methods, diagnostic endoscopy (i.e., bronchoscopy) and the histology of the biopsy material are major aides in the diagnosis of primary character, location, and operability, as well as in the elaboration of the surgical plans, than it is usual in cases of other tumors.
INTRODUCTION
Eighty-eight percent ofthe primary malignant melanomas appear in the skin or the eye (1) . As primary tumors, melanomas occur considerably less frequently in the oral cavity, upper respiratory tract, esophagus, liver, gall bladder, ovaries, cervix uteri, uterus, urogenital system, and leptomeninx. The malignant melanoma usually occurs as a metastatic tumor in the lower respiratory tract and/or lung (in 7% to 9% of those of cutaneous origin and in 2% of the autopsies) (2, 3) , and the primary forms of the same localization are extremely rare. It is assumed that the primary melanomas derive from the benign melanocytes moving together with the mesoderm and/or entoderm (4, 5) . Similar cells have been isolated from the mucosa of the esophagus and larynx. The latter organs derive from the 6th branchial arch as parts of the pulmonal system. Nevertheless, the presence of even benign melanocytes in the bronchopulmonary system is not usual (6) . According to some suggestions, melanocytic metaplasy also may take place under various stimuli in epithelial cells, salivary glands, and nervous structures (7) . It is possible also that some precursor cells (e.g., Kultschitsky cells) may undergo both neuroendocrine and melanocytic differentiation (8, 9, 15) .
A careful analysis of the literature reveals that the majority of the really primary malignant melanomas located in the lower respiratory tract and/or lung have been described in English-speaking countries (Table 1) ; we find only Danish (11) , French (12) , and Spanish (13) publications in Europe, in addition to those in Great Britain (5,13a-21) . Thus, we describe observations obtained from our two patients and survey the relatively few publications. 
CASE REPORTS
Mrs. B. J. is a 43-year-old patient. In her anamnesis there was a uterus exstirpation because of myomas. She recovered in our department on November 3, 1989 , because of shadow seen by X-ray examination in the left thoracal region. She has been coughing for several weeks and is occasionally febrilic. Physical examination did not reveal any alterations on the skin; no lymph nodes could be found. The repeated posteroanterior summation X-ray examination and tomographic imaging of the left side in planes of sagittal direction revealed a round vascular shadow about 6 to 7 cm in the left hilar region (Figure 1 ). Bronchoscopy revealed the presence of a tumor at the beginning of the left upper lobe bronchus; the tumor was about 8 mm with a slightly uneven surface and browngray color (Figure 2 Diagnosis: Melanoma malignum bronchi lobi superioris pulmonis sinistri. Metastasis tumoris in lymphonodo hili pulmonis sinistri.
Opinion: The tumor is considered a primary bronchial melanoma. This opinion is supported by the following morphologic signs: a single tumor of central location in the bronchial lumen; the polypoid surface of the tumor covered by an epithelium displaying atypical melanocytic proliferation and atypical planocellularmetaplasy, and epithelium naevoid cell nests confluent with the tumor (Figures 3--4) .
The postoperative period was without complication. The patient received Deticen (dacarbasin) therapy in 12 cycles during the first postoperative year.
The metastatic origin of this tumor in the bronchus of the left upper lobe of lung could be excluded with high probability based on the negative results of dermatologic, otorhinolaryngologic, oculistic, and gynecologic, and abdominal ultrasound examinations. Because the skin did not show any alteration, excision from the skin was not performed. Currently, the patient suffers only from an effort dyspnoe and otherwise is without complaint. She gained about 10 kg body weight. Urine analyses using Thormilen and Jaksch tests for melanin proved negative. Mrs. K. L., age 81 years complained ofdiffuse chest pains and dyspnoe. X-ray examination showed an egg-sized shadow in the segment 10 of the left side and a lymph node conglomerate in the hilus ( Figure 5 ). Bronchoscopy was performed on November 21, 1990 and revealed that the lower part of the left main bronchus was almost completely closed by a tumorous gray-brown mass infiltrating the bronchial wall and penetrating from the direction of the bronchus of the lower lobe ( Figure 6 ). To increase the bronchial lumen and improve the drainage, small parts of the tumor were removed. This intervention was repeated after 2 weeks, because the patient reported an improvement of her condition. Histologically, the tumor is rich in cells and already has reached the surface of the bronchial mucosa. The tumor cells form solid groups, are medium-size with partly pale, eosinophilic cytoplasm, and contain numerous, focally localized, finely distributed, brownish, melaninlike pigment granules. The cell nuclei are hyperchromic and are ovoid or elongated, and some contain large nucleoli. There is an exo pressed cellularatypia andpolymorphism. The brownish pigment tested positive for Grimelius and Masson-Fontana silver stainings, and the immunohistochemical HMB-45 melanomaresult was also positive. All these results supported the diagnosis of melanoma malignum. The biopsy material also was analyzed electromicroscopically; the cells containing the brownish melaninlike pigment also displayed numerous premelanosomes or melanosomes of high electron density (Figures 7 and 8) .
The patient was observed for 4 months and was hospi- toIogic analyses remained negative for melanoma, therefore no skin biopsy was performed. Otorhinolaryngologic, oculistic, neurologic, and gynecologic, and abdominal ultrasound examinations were negative. When the patient died from respiratory and circulatory insufficiency, autopsy could not be performed because family consent was not available.
DISCUSSION
The first authentic primary malignant bronchopulmonal melanoma was described by Salm in 1963. In some of the cases described in later publications, one has to doubt the primary lung and/or bronchial origin. (22) (23) (24) (25) (26) . The most serious issue is the exclusion of the metastatic origin of the tumor, because according to some opinions, skin melanomas may spontaneously disappear without any trace after they already have metastased. (2, 27) . However even if one accepts the possibility of the eventual, rare spontaneous regression of the primary skin melanoma, Figure 7 Melanoblastic proliferative mass infiltrating the bronchial wall x 65, hematoxylin-eosin staining. one should generally expect a later generalization (27). It is also a fact that more than 15% of the metastatic melanomas have a hidden primary tumor (28 The macroscopic and histologic properties ofthe tumor may offer further evidence for the origin ofthe tumor from the lower respiratory tract (6, 15, 21, 29) . Primary process is likely, if the tumor is polypoid and localized intraluminally, whereas the metastases are usually disseminated. The histologic conditions include:
1. Junctional alterations with the nestlike location or "dropping" of the melanoma cells 2. Invasion of melanoma cells in the bronchial epithelium at non-eroded places 3. Intraepithelial alterations that correspond unanimously to melanoma.
An accessory sign is considered to be the presence of naevuslike alteration in the bronchial epithelium nearby to the tumor and the melanoma flare that somewhat more distant from the tumor. (6, 15, 21) . In our first reported case, the listed histologic criteria were present, whereas in our second case, not all criteria could be met, mainly because of the small size of the bioptic materials. Generally speaking, the above criteria are considered valid, although the autopsy cannot always be performed, as described in some published cases, because of long postoperative survival or other reasons. On the other hand, autopsy itself has some limitations especially in answering the dilemma of primary tumor or metastasis. Therefore, if the obduction cannot be performed, the negative outcome of an extensive search for primary tumor in vivo can be accepted. Using modem endoscopic and imaging procedures, the probability of error can be reduced. Therefore, although the criteria defined by JensenEgedorf (1967) for the diagnosis of the primary malignant melanoma of the lower respiratory tract should be considered the standard, cases should be qualified based on the analysis of all test results and on common sense.
In both our cases, we found a solitary tumor with metastases in the hilus of the identical side. The malignant melanoma was proved by histologic, histochemic, and electron microscopic techniques. The tumors did not show any morphologic signs that suggested their metastatic ongn.
According to the data (see Table 1 ), the primary malignant melanoma ofthe lower respiratory tract and/or lung involves both sexes almost equally. At time of diagnosis, the youngest patient was 33, the oldest 81 years of age. Of the 14 operated cases (lobectomy and pulmonectomy), two and one patients, respectively, are still alive, i.e., after3 to4 years, and one patient in each group survived after 10 to 11 years. Three patients were alive 2 to 30 months after the intervention. Five patients died between 5.5 and 22 months, and one patient died during the postoperative phase of tracheal resection. There was one patient who underwent successful fight lower lobectomy the whose survival is not known.
The tumor was endobronchial in seven patients, and was intratracheal in one patient. The endobronchial location was accompanied by the involvement of the adjacent lung area in two persons, and exclusive parenchymal location was seen in eight cases. These facts indicate the significance of the bronchoscopy in the diagnosis. Operability and Survival are determined not by the bronchial or parenchymal location but by extension and circumscription of the tumor. The presence of a solitary, metastatic hilar lymph node, even if it is of considerable size, does not predict an unequivocal bad prognosis, as was shown in our first case.
In the therapy ofthe primary malignant melanoma ofthe lower respiratory tract, surgical removal is most important; considerable survival can be expected only from this intervention. The cytostatic treatments applied so far in the inoperable cases did not give any result; the effects of the adjuvant treatments cannot be measured either. Therefore, the main task is to detect the tumor as early as possible and if operable, surgical intervention must be performed.
